Advertisement

Index by author

December 01, 2020; Volume 375,Issue 3

  1. Abbruscato, Thomas J.

    1. The Role of Smoking and Nicotine in the Transmission and Pathogenesis of COVID-19
      Ali Ehsan Sifat, Saeideh Nozohouri, Heidi Villalba, Bhuvaneshwar Vaidya and Thomas J. Abbruscato
      Journal of Pharmacology and Experimental Therapeutics December 2020, 375 (3) 498-509; DOI: https://doi.org/10.1124/jpet.120.000170

  2. Albarazanji, Kamal

    1. Open Access
      Targeting Enteropeptidase with Reversible Covalent Inhibitors To Achieve Metabolic Benefits
      Weimei Sun, Xuqing Zhang, Maxwell D. Cummings, Kamal Albarazanji, Jiejun Wu, Mina Wang, Richard Alexander, Bin Zhu, YueMei Zhang, James Leonard, James Lanter and James Lenhard
      Journal of Pharmacology and Experimental Therapeutics December 2020, 375 (3) 510-521; DOI: https://doi.org/10.1124/jpet.120.000219

  3. Alexander, Richard

    1. Open Access
      Targeting Enteropeptidase with Reversible Covalent Inhibitors To Achieve Metabolic Benefits
      Weimei Sun, Xuqing Zhang, Maxwell D. Cummings, Kamal Albarazanji, Jiejun Wu, Mina Wang, Richard Alexander, Bin Zhu, YueMei Zhang, James Leonard, James Lanter and James Lenhard
      Journal of Pharmacology and Experimental Therapeutics December 2020, 375 (3) 510-521; DOI: https://doi.org/10.1124/jpet.120.000219

  4. Aucoin, David

    1. Monoclonal Antibodies Counteract Opioid-Induced Behavioral and Toxic Effects in Mice and Rats
      Carly Baehr, April Huseby Kelcher, Aaron Khaimraj, Dana E. Reed, Sujata G. Pandit, David AuCoin, Saadyah Averick and Marco Pravetoni
      Journal of Pharmacology and Experimental Therapeutics December 2020, 375 (3) 469-477; DOI: https://doi.org/10.1124/jpet.120.000124

  5. Averick, Saadyah

    1. Monoclonal Antibodies Counteract Opioid-Induced Behavioral and Toxic Effects in Mice and Rats
      Carly Baehr, April Huseby Kelcher, Aaron Khaimraj, Dana E. Reed, Sujata G. Pandit, David AuCoin, Saadyah Averick and Marco Pravetoni
      Journal of Pharmacology and Experimental Therapeutics December 2020, 375 (3) 469-477; DOI: https://doi.org/10.1124/jpet.120.000124

  6. Baehr, Carly

    1. Monoclonal Antibodies Counteract Opioid-Induced Behavioral and Toxic Effects in Mice and Rats
      Carly Baehr, April Huseby Kelcher, Aaron Khaimraj, Dana E. Reed, Sujata G. Pandit, David AuCoin, Saadyah Averick and Marco Pravetoni
      Journal of Pharmacology and Experimental Therapeutics December 2020, 375 (3) 469-477; DOI: https://doi.org/10.1124/jpet.120.000124

  7. Biyani, Kalpesh

    1. Mechanism of Action of Veverimer: A Novel, Orally Administered, Nonabsorbed, Counterion-Free, Hydrochloric Acid Binder under Development for the Treatment of Metabolic Acidosis in Chronic Kidney Disease
      Open Access
      Mechanism of Action of Veverimer: A Novel, Orally Administered, Nonabsorbed, Counterion-Free, Hydrochloric Acid Binder under Development for the Treatment of Metabolic Acidosis in Chronic Kidney Disease
      Gerrit Klaerner, Jun Shao, Kalpesh Biyani, Matthew Kade, Paul Kierstead, Randi Gbur, Scott Tabakman, Son Nguyen and Jerry Buysse
      Journal of Pharmacology and Experimental Therapeutics December 2020, 375 (3) 439-450; DOI: https://doi.org/10.1124/jpet.120.000190

  8. Brinckmann, Jürgen

    1. Minoxidil Cannot Be Used To Target Lysyl Hydroxylases during Postnatal Mouse Lung Development: A Cautionary Note
      Minoxidil Cannot Be Used To Target Lysyl Hydroxylases during Postnatal Mouse Lung Development: A Cautionary Note
      Tilman Pfeffer, Ettore Lignelli, Hajime Inoue, Ivana Mižíková, David E. Surate Solaligue, Heiko Steenbock, Despoina Myti, István Vadász, Susanne Herold, Werner Seeger, Jürgen Brinckmann and Rory E. Morty
      Journal of Pharmacology and Experimental Therapeutics December 2020, 375 (3) 478-487; DOI: https://doi.org/10.1124/jpet.120.000138

  9. Buysse, Jerry

    1. Mechanism of Action of Veverimer: A Novel, Orally Administered, Nonabsorbed, Counterion-Free, Hydrochloric Acid Binder under Development for the Treatment of Metabolic Acidosis in Chronic Kidney Disease
      Open Access
      Mechanism of Action of Veverimer: A Novel, Orally Administered, Nonabsorbed, Counterion-Free, Hydrochloric Acid Binder under Development for the Treatment of Metabolic Acidosis in Chronic Kidney Disease
      Gerrit Klaerner, Jun Shao, Kalpesh Biyani, Matthew Kade, Paul Kierstead, Randi Gbur, Scott Tabakman, Son Nguyen and Jerry Buysse
      Journal of Pharmacology and Experimental Therapeutics December 2020, 375 (3) 439-450; DOI: https://doi.org/10.1124/jpet.120.000190

  10. Calabresi, Laura

    1. Activation of Naturally Occurring Lecithin:Cholesterol Acyltransferase Mutants by a Novel Activator Compound
      Chiara Pavanello, Alice Ossoli, Marta Turri, Arianna Strazzella, Sara Simonelli, Tommaso Laurenzi, Keita Kono, Keisuke Yamada, Naoki Kiyosawa, Ivano Eberini and Laura Calabresi
      Journal of Pharmacology and Experimental Therapeutics December 2020, 375 (3) 463-468; DOI: https://doi.org/10.1124/jpet.120.000159
« Previous (Pages : 1 2 3 4 5 6 ... 10) Next »
Back to top

In this issue

Advertisement